The new rules will enable EMA to closely monitor and mitigate shortages of drugs and medical devices in critical and public health emergencies, and facilitate faster approval of drugs that help treat diseases that are causing the public health crisis. The adoption of a stronger EMA mandate is part of the European Health Union package, proposed by the Commission in November 2020.
- Today's adoption marks a milestone for Union citizens who expected the EU to put in place the right tools to respond quickly and effectively to health crises. Over the past two years, the European Medicines Agency has been a key body in the EU's response to the COVID-...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
